CN Patent

CN102382065B — 苯胺取代的喹唑啉衍生物

Assigned to Xuanzhu Biopharmaceutical Co Ltd · Expires 2014-05-28 · 12y expired

What this patent protects

本发明属于医药技术领域，具体涉及通式(I)所示的苯胺取代的喹唑啉衍生物、其药学上可接受的盐或其立体异构体：其中R 1 、R 2 、R 3 、R 4 、R 5 、R 6 、L或n如说明书中所定义；本发明还涉及这些化合物的制备方法，含有这些化合物的药物制剂，以及这些化合物在制备治疗肿瘤的药物中的用途。

USPTO Abstract

本发明属于医药技术领域，具体涉及通式(I)所示的苯胺取代的喹唑啉衍生物、其药学上可接受的盐或其立体异构体：其中R 1 、R 2 、R 3 、R 4 、R 5 、R 6 、L或n如说明书中所定义；本发明还涉及这些化合物的制备方法，含有这些化合物的药物制剂，以及这些化合物在制备治疗肿瘤的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN102382065B
Jurisdiction
CN
Classification
—
Expires
2014-05-28
Drug substance claim
No
Drug product claim
No
Assignee
Xuanzhu Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.